Physician profile
Eric Newman
NPI 1679707301
$2,113.06
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.15 · 2022: $1,792 · 2023: $216 · 2024: $69.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,729.03 | 2022-2024 | Oasis, Acticoat 4" X 4", Collagenase Santyl |
| Mallinckrodt Hospital Products INC. | $146.72 | 2022 | |
| Kci USA, INC. | $62.69 | 2022-2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
| Hydrofera LLC | $28.67 | 2021-2022 | |
| Medline Industries Lp | $27.51 | 2024 | Medline Industries, INC. |
| Bioventus LLC | $27.14 | 2022 | |
| Vericel Corporation | $22.27 | 2023 | Epicel (Cultured Epidermal Autografts) |
| Organogenesis INC. | $20.84 | 2021 | |
| Integra Lifesciences Corporation | $18.50 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Convatec INC. | $15.38 | 2022 | |
| Baxter Healthcare | $14.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.